Research

RMIT, Glyscend and Neurotrack each receive U.S. $500,000 research grant and offered residency at Johnson & Johnson Innovation | JLABS

Challenge Reflects Company’s Comprehensive Approach to Advancing Health and Innovation on the Continent

Award Funding Extends Company’s Ongoing Commitment to Supporting Underserved Communities in the United States

Largest QuickFire competition to date will award up to $500,000 in a research grant and entrance to Johnson & Johnson Innovation, JLABS, to promising transformational healthcare solution Challenge launched at 2016 BIO International Convention during the Bionic Innovation Forum

As part of an ongoing commitment to support life sciences innovators and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases, Johnson & Johnson today named cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology the winner of the 2016 Dr. Paul Janssen Award for Biomedical Research for his pioneering discoveries concerning the molecular basis of autophagy.

22 resident companies selected for novel life science ecosystem featuring digital prototype lab and collaborative work environment

Johnson & Johnson Innovation, JLINX will offer scientists and entrepreneurs access to venture funding, R&D expertise and state-of-the-art facilities JLINX is designed to accelerate early-stage transformative innovation, including an emphasis on the human microbiome as well as broader life-science research

New life sciences facility opens with first 21 resident companies, medical device prototype lab, and collaborative work environment